1. Home
  2. NAII vs CING Comparison

NAII vs CING Comparison

Compare NAII & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAII
  • CING
  • Stock Information
  • Founded
  • NAII 1980
  • CING 2012
  • Country
  • NAII United States
  • CING United States
  • Employees
  • NAII N/A
  • CING N/A
  • Industry
  • NAII Medicinal Chemicals and Botanical Products
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAII Health Care
  • CING Health Care
  • Exchange
  • NAII Nasdaq
  • CING Nasdaq
  • Market Cap
  • NAII 21.2M
  • CING 22.0M
  • IPO Year
  • NAII 1987
  • CING 2021
  • Fundamental
  • Price
  • NAII $3.01
  • CING $3.70
  • Analyst Decision
  • NAII
  • CING Strong Buy
  • Analyst Count
  • NAII 0
  • CING 4
  • Target Price
  • NAII N/A
  • CING $31.00
  • AVG Volume (30 Days)
  • NAII 6.3K
  • CING 132.0K
  • Earning Date
  • NAII 11-12-2025
  • CING 11-06-2025
  • Dividend Yield
  • NAII N/A
  • CING N/A
  • EPS Growth
  • NAII N/A
  • CING N/A
  • EPS
  • NAII N/A
  • CING N/A
  • Revenue
  • NAII $125,483,000.00
  • CING N/A
  • Revenue This Year
  • NAII N/A
  • CING N/A
  • Revenue Next Year
  • NAII N/A
  • CING N/A
  • P/E Ratio
  • NAII N/A
  • CING N/A
  • Revenue Growth
  • NAII 4.39
  • CING N/A
  • 52 Week Low
  • NAII $2.57
  • CING $3.02
  • 52 Week High
  • NAII $6.75
  • CING $6.01
  • Technical
  • Relative Strength Index (RSI)
  • NAII 32.50
  • CING 39.94
  • Support Level
  • NAII $3.28
  • CING $3.70
  • Resistance Level
  • NAII $3.87
  • CING $4.00
  • Average True Range (ATR)
  • NAII 0.17
  • CING 0.23
  • MACD
  • NAII -0.07
  • CING 0.02
  • Stochastic Oscillator
  • NAII 11.54
  • CING 15.27

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: